Marx Biotechnology

  • Year founded:
2014
  • Vertical:
Biotechnology, Health Care, Life Sciences.
  • The problem:
Marx Biotechnology is developing a blood test to diagnose the early onset of acute graft versus host disease (aGVHD), the leading cause of death in bone marrow transplants. Fifty percent of individuals who get a bone marrow transplant will develop GVHD and out of that fifty percent will die.
  • The solution:
Marx Biotechnology’s blood test diagnoses the early onset of aGVHD by monitoring the functions on the molecular level that have to change for the disease to occur. Definitive results available within 2 hours allowing physicians to make quick, accurate and efficient decisions on how to manage and treat their patients.
  • Target markets:
Bone marrow transplant facilities, Globally, there are more than 700 bone marrow transplant facilities.
  • The team:

Stephen Marx Ph.D. – Founder, CEO

Ariel Orbach Ph.D. – CTO

Meir Silver Ph.D. – Vice president for clinical research and regulatory affairs

  • Stage:
Late Seed stage, Round A.
  • Year founded:
2014
  • Vertical:
Biotechnology, Health Care, Life Sciences.
  • The problem:
Marx Biotechnology is developing a blood test to diagnose the early onset of acute graft versus host disease (aGVHD), the leading cause of death in bone marrow transplants. Fifty percent of individuals who get a bone marrow transplant will develop GVHD and out of that fifty percent will die.
  • The solution:
Marx Biotechnology’s blood test diagnoses the early onset of aGVHD by monitoring the functions on the molecular level that have to change for the disease to occur. Definitive results available within 2 hours allowing physicians to make quick, accurate and efficient decisions on how to manage and treat their patients.
  • Target markets:
Bone marrow transplant facilities, Globally, there are more than 700 bone marrow transplant facilities.
  • The team:

Stephen Marx Ph.D. – Founder, CEO

Ariel Orbach Ph.D. – CTO

Meir Silver Ph.D. – Vice president for clinical research and regulatory affairs

  • Stage:
Late Seed stage, Round A.
נגן וידאו

Contact info:

  • Stephen Marx Ph.D., Founder & CEO
  • Mail:
stephengmarx@gmail.com
  • Phone:
IL: +972-52-869-3366
US: 469-248-3438

Contact info:

  • Stephen Marx Ph.D., Founder & CEO
  • Mail:
stephengmarx@gmail.com
  • Phone:
IL: +972-52-869-3366
US: 469-248-3438

הרשמה לניוזלייטר מקצועי

קבלו תוכן מקצועי מעשיר בהתאם לקהילה שבחרתם

קבלו תוכן מקצועי מעשיר בהתאם לקהילה שבחרתם

צור קשר

©All rights reserved bizlabs 2022

X
דילוג לתוכן